Psilocybin papers
Find psilocybin papers by title, author, DOI or PMID. Browse source-labeled research articles, distinguish preprints, and export citations for free.
Free access · No subscription for research tools or data exports
Find a psilocybin paper and its original source
Search psilocybin research papers by title, author, journal, DOI or PubMed identifier. Open a record to check its source, publication status and citation context. This collection focuses on published records, reviews and protocols in the index; source labels are metadata, not an independent certification of peer review.
Find a specific paper
Paste the DOI or PMID when you know it. For a title search, use distinctive words. Confirm the author list, journal, date and identifier against the original publication before citing.
Find evidence for a broader questionRead the original research article
The database links source records and DOI resolvers. It provides bibliographic metadata and selected original annotations; publisher abstracts and full texts are not redistributed here without verified rights.
Public fields and reuse rightsExport a citation
Save records to your workspace or select them in the main search. Export BibTeX, RIS, CSV, JSON or LaTeX and check the citation style required by your journal.
Build and export a reading listInclude preprints deliberately
This paper collection keeps preprints separate. The main index includes them with a visible warning so you can evaluate early reports without confusing them with peer-reviewed findings.
Psilocybin preprints — not peer reviewedBrowse indexed psilocybin papers
4184 matching records; first 20 shown. Derived labels aid screening and need verification against the methods. Coverage is broad but not exhaustive.
Single-dose psilocybin superior to placebo for MDD in community setting · 2026-12-01 · The Brown University Psychopharmacology Update · PublishedPilot study supports broader research on psilocybin for anorexia nervosa · 2026-12-01 · The Brown University Psychopharmacology Update · PublishedSingle dose of psilocybin shows extended benefit in depression trial · 2026-12-01 · The Brown University Psychopharmacology Update · PublishedQuantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurementPérez Rosal Sergio R., Faber Sonya C. · 2026-12-01 · Psychedelics · PublishedMindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery modelAlbertyn Christopher P., Richard Jérémie, Shore Ron, Carlson Linda E. · 2026-12-01 · Psychedelics · PublishedPsilocybin reproducibilityLewis Sian · 2026-11-19 · Nature Reviews Neuroscience · PublishedMescaline enhances emotional empathy via 5-HT receptor activation.Klaiber A, Vizeli P, Varghese N, Eckert A, Liechti ME, Schmid Y · 2026-11-19 · Journal of psychopharmacology (Oxford, England) · PublishedTargeting CGRP signaling reverses maladaptive neurogenic immunosuppression in head and neck squamous cell carcinoma models.Idlett-Ali SL, Nguyen AT, Abdelazeem KN, Nguyen D, Olimpo NA, Knitz M, Gadwa J, Weiskpof T, Hodgson C, Kumar H, Ceja Galindo D, Gray T, Puram SV, Miller DL, Nicol GE, Saviola AJ, Osborne DG, Karam SD · 2026-11-19 · The Journal of clinical investigation · PublishedTaxonomic diversity and psilocybin detection in “superfamily” Strophariacea from China, with descriptions of two new speciesCao Bin, Yang Wen-Qiang, Feng Hai-Ying, He Mao-Qiang, Li Jia-Xin, Zhao Rui-Lin, Phurbu Dorji · 2026-11-18 · IMA Fungus · PublishedNovel quantification method for psilocin in brain tissues using liquid chromatography-tandem mass spectrometry.Khajavinia A, Reekie J, Michel D, Laprairie RB, El-Aneed A. · 2026-11-18 · Analytical methods: advancing methods and applications · PublishedPsychedelic treatment for headache disorders.Zorrilla E, Schindler EAD. · 2026-11-17 · Nature reviews. Neurology · PublishedPrior trauma shapes the effects of psilocybin on stress sensitization in mice.Ottofaro SR, Maltman JL, González-Maeso J · 2026-11-15 · Neuroscience letters · PublishedCost-effectiveness of psychedelic-assisted therapies for depression and post-traumatic stress disorder: A systematic review.Sheikhrobat MV, Jaberi N, Tahmasebi-Ghorrabi A, Shamsaei M. · 2026-11-13 · Psychiatry research · PublishedRoots to Thrive risk and readiness assessment: a practice-based intake and decision-support framework for psychedelic-assisted therapy.Dames SS, Tsang VWL, Sheffield J, Fehlau B, McLachlan S, Kryskow P · 2026-11-13 · BMJ open quality · PublishedCurrent perspectives in the pharmacological treatment of gambling disorder: psychedelics and beyond.Chiappini S, Maremmani AGI, Cavallotto C, Marrangone C, Amerio A, Lupi M, Pettorruso M, Martinotti G. · 2026-11-13 · Expert opinion on pharmacotherapy · PublishedPsilocybin enhances conditioned place preference learning in planarians.Ellenbroek BA, Naylor B, Youn J. · 2026-11-13 · Behavioural pharmacology · PublishedConnectedness as a candidate pathway linking psilocybin retreat experiences to sustained wellbeing: a prospective naturalistic studyÅkesson M, Granqvist P, Johansson R, Gruneau Brulin J. · 2026-11-12 · Frontiers in psychiatry · PublishedFrom Rapid Synaptic Events to Lasting Antidepressant States: Convergent and Divergent Mechanisms of Ketamine and Psychedelics.Kim J, Fogaca MV, Munguba H, Pignatelli M, Platholi J, Woodburn SC, Ma 马振中 ZZ. · 2026-11-11 · The Journal of neuroscience: the official journal of the Society for Neuroscience · PublishedThe "dark magic mushroom" co-produces amatoxins and psilocybin.Kunik AR, Christopher MW, Lemmond B, Dentinger BTM, Slot JC, Garrett TJ, Smith ME. · 2026-11-11 · Current biology: CB · PublishedPsychedelic-assisted therapies (Psilocybin and MDMA) for treatment-resistant psychiatric disordersGurgel Maria Luiza Góes, Ferreira Ana Luísa Carrijo, Mello Luisa da Costa, Caldato Amanda Comandolli, Canto Sofia Zaher do, Camilotti Pietra Brossi, Silva Manuela Ruela Folino, Gomes Raissa Assalin, Wiltemburg Beatriz Bomfim, Perini Giulia Spadone, Bertipaglia Manoela Rosa, Matos Rafaella Barcelos de, Orsi Enzo Seletti, Nacle Fernanda Oliveira, Ribeiro Gabriela Fernandes Daniel · 2026-11-10 · International Health Sciences Review · Published
Research questions with source-linked context
Psilocybin studies for depressionPsilocybin and alcohol-use studiesTopics, selected reports and outcome measuresPublication trends and denominators
Publication dates, study dates and indexing dates may differ. Clinical trial registrations describe planned methods, while primary reports describe findings. Read the editorial policy for source tracking, corrections and classification limits.